+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

Visiongain Publishes Laboratory Information Management System (LIMS) Market Forecast 2020-2030

09 August 2020
Pharma

Visiongain has launched a new report Laboratory Information Management System (LIMS) Market Forecast 2020-2030: Forecasts and Analysis by Product, by Component, by End-use and Geography, with Profiles of Leading Companies.

According to the report published by Visiongain, the World Laboratory Information Management System (LIMS) market was valued at approximately USD xx billion in 2019 and is expected to grow at a CAGR of around xx% between 2020 and 2030. Experimental information management systems belong to the application software category designed to store and handle information obtained through laboratory work. Samples, requirements, test results, documentation, labs, equipment and process electronic processes are handled and regulated using these programs. The integration of laboratory information management systems with company information systems will allow required data to be transmitted promptly to the laboratory and company management. Key words Data Monitoring Programs–Information Management Strategies–Informations Management Systems laboratories–LIMS features

World Laboratory Information Management System (LIMS) Market is witnessing Growth due to factors such as
The growth of the R&D laboratories, particularly in pharmaceutical and biotech laboratories, is likely to boost market growth during the forecast period. Increased emphasis on increasing lab performance will also lead to the huge growth of the industry in the coming years. However, low cost of deployment, effective time management and conformity with GDP, GCP and GMP are the main factors through LIMS production. In addition, growing genome and DNA studies practices, as well as in-vitro ADME technology works towards the market. Also expected to bring a fill to the market are associated advantages, such as high precision and manually eliminated data transcription mistakes. In fact, the success of cloud-based systems is expected to affect overall market development positively.

Analytic laboratories perform a range of functions including the quality control of raw materials, intermediate products and finished products; metrological measurement technique certification; ecological management; routine measuring instruments inspection; external laboratory and internal auditing; and many more. It is evident that the successful realization of such multifaceted activity requires the utilization of information and information management system when considering the structure and functions of analytical laboratories. A compound of the hardwared and computer elements designed for the storage and metrological processing of the measuring data obtained by the screening of specimens for analysis are the information management device used in an analytical laboratory.

An IM Program is a complex of components of hardware and software that facilitates the control of the compilation, sorting, storage, dissemination and monitoring procedures used with information gathered by research activities. Establishing such types of systems is based on efforts to automate laboratory procedures to increase the laboratory efficiency and productivity of the various analysis objects processing, improve the quality control system, etc. A large number of companies worldwide (over 100) are now manufacturing these types of software products. These companies all use certain specification documents and documents that regulate their activities, including a laboratory information management system standard based on the national Russian standard.

Shift in Trends
A compute-based database technology is a laboratory information management program used in the laboratory to perform analyzes and standard test tests, laboratory staff, and diagnostic instruments, as well as to generate consumer reports and other functions. A laboratory information management system The roles of laboratory data management systems also include the control of experimental workflows, information obtained in the laboratory, and interaction with equipment and other manufacturing computer systems.

The collection of documents of all kinds, including reliability certificates, research protocols and sample certifications, is one of the main functions of the laboratory information management system; it also has the task of modifying reports for a specific user. In order to make it easy for the user, it is essential to support the use of standard report-generating software products in manual or automatic mode by using a variety of user software (for example, a graphical user interface must be present to build graphs) and to standardize the report forms. Most often, the capability to implement an electronic signature, in particular, in the form of a graphics file, is integrated into a laboratory information management system. The system must also be capable of printing out reports for authorized specialists as well as transmitting reports by electronic mail.

Regional Market Analysis
In 2019, the demand in North America reported slightly over 45.00 million. Through supporting policies to facilitate laboratory automations such as EHR programes, the region will maintain its position in the international arena by 2025. Furthermore, the regional market is expanding due to the presence of advanced infrastructure, increased demand of genomic research and increased public funding.

Due to the increasing number of LIMS providing CROs in this region, the laboratory information management systems market in the Asian Pacific is expected to exhibit the highest CAGR during the forecast period. In 2016, India ranked among 55 analyzed countries in the outsourcing of web-enabled services, according to the Global Services Location Index (GSLI) rating.

Competition in the market
The Laboratory Information Management System (LIMS) international industry is made up of Abbott Laboratories, LabLynx Inc., Thermo Fisher Scientific, Inc., Promium LLC., Siemens Group SA, Novatek Corporation, LabWare and PerkinElmer Inc., among the leading actors in the world market. To order to meet the competitive environment, companies are constantly creating and innovating new products. Partnerships with other leaders of the industry, need for R&D and product separation are one of the main strategies for growing the concentration of market players.Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read